C.J. Porter

938 total citations
20 papers, 708 citations indexed

About

C.J. Porter is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, C.J. Porter has authored 20 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in C.J. Porter's work include Parathyroid Disorders and Treatments (6 papers), Acute Kidney Injury Research (5 papers) and Vitamin D Research Studies (4 papers). C.J. Porter is often cited by papers focused on Parathyroid Disorders and Treatments (6 papers), Acute Kidney Injury Research (5 papers) and Vitamin D Research Studies (4 papers). C.J. Porter collaborates with scholars based in United Kingdom, Australia and France. C.J. Porter's co-authors include Michael Cassidy, Aristeidis Stavroulopoulos, A G Morgan, Mark A.J. Devonald, Irene Juurlink, D. J. Hosking, Nicola Peat, J. E. Taylor, Rajnikant Mehta and Kate Pointon and has published in prestigious journals such as Kidney International, Transplantation and American Journal of Transplantation.

In The Last Decade

C.J. Porter

20 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.J. Porter United Kingdom 14 421 140 131 123 88 20 708
Masao Kim Japan 11 397 0.9× 183 1.3× 76 0.6× 140 1.1× 29 0.3× 24 611
Mercè Borràs Spain 14 470 1.1× 162 1.2× 81 0.6× 123 1.0× 33 0.4× 44 837
Jocelyn S. Garland Canada 16 372 0.9× 80 0.6× 61 0.5× 117 1.0× 89 1.0× 30 812
Cristina Jorge Portugal 9 316 0.8× 198 1.4× 89 0.7× 74 0.6× 26 0.3× 39 501
Praveen Kandula United States 12 330 0.8× 219 1.6× 97 0.7× 144 1.2× 18 0.2× 17 667
Ángel Francisco Spain 18 490 1.2× 67 0.5× 60 0.5× 134 1.1× 187 2.1× 40 838
J.M. Hurot France 11 666 1.6× 214 1.5× 55 0.4× 151 1.2× 33 0.4× 14 828
Luigi Morrone Italy 18 422 1.0× 90 0.6× 71 0.5× 95 0.8× 77 0.9× 36 776
Davide Rolla Italy 14 484 1.1× 142 1.0× 79 0.6× 106 0.9× 47 0.5× 30 796
José Manuel González‐Posada Spain 21 541 1.3× 116 0.8× 152 1.2× 373 3.0× 25 0.3× 46 1.3k

Countries citing papers authored by C.J. Porter

Since Specialization
Citations

This map shows the geographic impact of C.J. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Porter more than expected).

Fields of papers citing papers by C.J. Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Porter. The network helps show where C.J. Porter may publish in the future.

Co-authorship network of co-authors of C.J. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of C.J. Porter. A scholar is included among the top collaborators of C.J. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.J. Porter. C.J. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porter, C.J., Elisheva Coleman, Lynda Ross, & Michelle Palmer. (2019). Do stroke patients screened as lower‐nutritional‐risk still receive dietitian assessment if indicated? A retrospective evaluation of two dietetic models of care for adult stroke patients. Journal of Human Nutrition and Dietetics. 32(2). 267–275. 3 indexed citations
2.
Gilbert, Brian W., et al.. (2018). Pharmacoeconomic impact of an alternative workflow process for stroke. The American Journal of Emergency Medicine. 37(2). 294–297. 2 indexed citations
3.
4.
Porter, C.J., et al.. (2014). A real-time electronic alert to improve detection of acute kidney injury in a large teaching hospital. Nephrology Dialysis Transplantation. 29(10). 1888–1893. 98 indexed citations
5.
Stavroulopoulos, Aristeidis, et al.. (2011). Evolution of coronary artery calcification in patients with chronic kidney disease Stages 3 and 4, with and without diabetes. Nephrology Dialysis Transplantation. 26(8). 2582–2589. 26 indexed citations
6.
Porter, C.J., et al.. (2007). Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes. Nephrology Dialysis Transplantation. 22(11). 3208–3213. 51 indexed citations
7.
8.
Stavroulopoulos, Aristeidis, et al.. (2007). Vitamin D Status in Renal Transplant Recipients. American Journal of Transplantation. 7(11). 2546–2552. 134 indexed citations
9.
Dasgupta, Indranil, C.J. Porter, Andrew J. Innes, & Richard Burden. (2006). 'Benign' hypertensive nephrosclerosis. QJM. 100(2). 113–119. 20 indexed citations
10.
Cartmell, Mark, Derek O’Reilly, C.J. Porter, & Andrew N. Kingsnorth. (2004). A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans. Journal of Hepato-Biliary-Pancreatic Surgery. 11(4). 255–259. 9 indexed citations
11.
Porter, C.J., et al.. (2004). Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism. Osteoporosis International. 16(2). 142–148. 31 indexed citations
12.
Taal, Maarten W., et al.. (2003). Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney International. 63(3). 1116–1120. 58 indexed citations
13.
Godber, Ian M, et al.. (2002). Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 39(3). 314–317. 13 indexed citations
14.
Porter, C.J., J Ronan, & Michael Cassidy. (2000). FAS-FAS-LIGAND ANTIGEN EXPRESSION AND ITS RELATIONSHIP TO INCREASED APOPTOSIS IN ACUTE RENAL TRANSPLANT REJECTION1. Transplantation. 69(6). 1091–1094. 16 indexed citations
15.
Porter, C.J., R. P. Burden, A G Morgan, Ian Daniels, & John Fletcher. (1997). Impaired Bacterial Killing and Hydrogen Peroxide Production by Polymorphonuclear IMeutrophils in End-Stage Renal Failure. Nephron. 77(4). 479–481. 11 indexed citations
16.
Daniels, Ian, C.J. Porter, Mark A. Lindsay, et al.. (1996). Hydrogen peroxide generation by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent. Clinical and Diagnostic Laboratory Immunology. 3(6). 682–688. 7 indexed citations
17.
Taylor, J. E., Nicola Peat, C.J. Porter, & A G Morgan. (1996). Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients. Nephrology Dialysis Transplantation. 11(6). 1079–1083. 83 indexed citations
18.
Porter, C.J., R. P. Burden, A G Morgan, Ian Daniels, & John Fletcher. (1995). Impaired Polymorphonuclear Neutrophil Function in End-Stage Renal Failure and Its Correction by Continuous Ambulatory Peritoneal Dialysis. ˜The œNephron journals/Nephron journals. 71(2). 133–137. 16 indexed citations
19.
Daniels, Ian, Mark A. Lindsay, C.J. Porter, et al.. (1993). Effect of Peritoneal Dialysis Effluent on Superoxide Anion Production by Polymorphonuclear Neutrophils. ˜The œNephron journals/Nephron journals. 64(3). 382–387. 17 indexed citations
20.
Haynes, Andrew, Ian Daniels, C.J. Porter, John Fletcher, & A G Morgan. (1992). Abnormal cytoplasmic pH regulation during activation in uremic neutrophils. Kidney International. 42(3). 690–699. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masao Kim Breakdown of academic impact, for papers by Mercè Borràs Breakdown of academic impact, for papers by Jocelyn S. Garland Breakdown of academic impact, for papers by Cristina Jorge Breakdown of academic impact, for papers by Praveen Kandula Breakdown of academic impact, for papers by Ángel Francisco Breakdown of academic impact, for papers by J.M. Hurot Breakdown of academic impact, for papers by Luigi Morrone Breakdown of academic impact, for papers by Davide Rolla Breakdown of academic impact, for papers by José Manuel González‐Posada
Rankless by CCL
2026